These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 2187813)

  • 1. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
    Schlageter AM; Kozel TR
    Infect Immun; 1990 Jun; 58(6):1914-8. PubMed ID: 2187813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D; Kozel TR
    Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
    Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
    Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.
    Yuan RR; Spira G; Oh J; Paizi M; Casadevall A; Scharff MD
    Infect Immun; 1998 Mar; 66(3):1057-62. PubMed ID: 9488395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of biologically active anti-Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis.
    Spira G; Paizi M; Mazar S; Nussbaum G; Mukherjee S; Casadevall A
    Clin Exp Immunol; 1996 Sep; 105(3):436-42. PubMed ID: 8809131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.
    Eckert TF; Kozel TR
    Infect Immun; 1987 Aug; 55(8):1895-9. PubMed ID: 2440810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies.
    Mukherjee S; Casadevall A
    J Clin Microbiol; 1995 Mar; 33(3):765-8. PubMed ID: 7751394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide.
    Sanford JE; Lupan DM; Schlageter AM; Kozel TR
    Infect Immun; 1990 Jun; 58(6):1919-23. PubMed ID: 2341184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotype can affect the fine specificity of an antibody for a polysaccharide antigen.
    McLean GR; Torres M; Elguezabal N; Nakouzi A; Casadevall A
    J Immunol; 2002 Aug; 169(3):1379-86. PubMed ID: 12133962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans.
    Nussbaum G; Yuan R; Casadevall A; Scharff MD
    J Exp Med; 1996 Apr; 183(4):1905-9. PubMed ID: 8666947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide.
    Dromer F; Salamero J; Contrepois A; Carbon C; Yeni P
    Infect Immun; 1987 Mar; 55(3):742-8. PubMed ID: 3546139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
    McGaw TG; Kozel TR
    Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.
    Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z
    Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
    Kozel TR; McGaw TG
    Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous expression of kappa and lambda light chains in a murine IgG3 anti-Cryptococcus neoformans hybridoma cell line.
    Spira G; Yuan R; Paizi M; Weisendal M; Casadevall A
    Hybridoma; 1994 Dec; 13(6):531-5. PubMed ID: 7737677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
    Duro RM; Netski D; Thorkildson P; Kozel TR
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):252-8. PubMed ID: 12626451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective murine monoclonal antibodies to Cryptococcus neoformans.
    Mukherjee J; Scharff MD; Casadevall A
    Infect Immun; 1992 Nov; 60(11):4534-41. PubMed ID: 1398966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.